Name: ARGENX SE (ARGX) Stock
Brand: ARGENX SE
Rating: 5.5 (3 reviews)

Question 1

What does ARGX do?

Accepted Answer

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. The company is headquartered in Amsterdam, Noord-Holland and currently employs 1,599 full-time employees. The company went IPO on 2014-07-10. The company is primarily engaged in creating and developing a pipeline of differentiated antibody therapeutics for the treatment of severe autoimmune diseases using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The firm develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. The company includes, but is not limited to: Empasiprubart, a complement inhibitor targeting C2, blocking the function of both the classical and lectin pathways, while leaving the alternative pathway intact, ARGX-119 an antagonist to the MuSK receptor with potential in multiple neuromuscular indications.

Question 2

What is the current price of ARGX stock?

Accepted Answer

The current stock price of ARGX.BR is 693.6 EUR. The price decreased by -0.49% in the last trading session.

Question 3

What is the dividend status of ARGENX SE?

Accepted Answer

ARGX.BR does not pay a dividend.

Question 4

What is the ChartMill rating of ARGENX SE stock?

Accepted Answer

ARGX.BR has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.

Question 5

What is the analyst forecast for ARGX.BR stock?

Accepted Answer

25 analysts have analysed ARGX.BR and the average price target is 837.1 EUR. This implies a price increase of 20.69% is expected in the next year compared to the current price of 693.6.

Question 6

How is the valuation of ARGENX SE (ARGX.BR) based on its PE ratio?

Accepted Answer

The PE ratio for ARGENX SE (ARGX.BR) is 64.88. This is based on the reported non-GAAP earnings per share of 10.69 and the current share price of 693.6 EUR.

Question 7

Can you provide the market cap for ARGENX SE?

Accepted Answer

ARGENX SE (ARGX.BR) has a market capitalization of 42.70B EUR. This makes ARGX.BR a Large Cap stock.

ARGENX SE (ARGX.BR) Stock Price, Forecast & Analysis

ARGX.BR Latest News, Press Relases and Analysis